It is safe to switch therapy from interferon beta or glatiramer acetate to oral therapy in patients with relapsing multiple sclerosis with stable disease. Issue 5 (9th February 2021)

Record Type:: Journal Article
Title:: It is safe to switch therapy from interferon beta or glatiramer acetate to oral therapy in patients with relapsing multiple sclerosis with stable disease. Issue 5 (9th February 2021)
Main Title:: It is safe to switch therapy from interferon beta or glatiramer acetate to oral therapy in patients with relapsing multiple sclerosis with stable disease
Authors:: Koch-Henriksen, Nils
Abstract:
Is Part Of:: Journal of neurology, neurosurgery and psychiatry. Volume 92:Issue 5(2021)
Journal:: Journal of neurology, neurosurgery and psychiatry
Issue:: Volume 92:Issue 5(2021)
Issue Display:: Volume 92, Issue 5 (2021)
Year:: 2021
Volume:: 92
Issue:: 5
Issue Sort Value:: 2021-0092-0005-0000
Page Start:: 457
Page End:: 457
Publication Date:: 2021-02-09
Subjects:: multiple sclerosis
Neurology -- Periodicals
Nervous system -- Surgery -- Periodicals
Psychiatry -- Periodicals
616.8
Journal URLs:: http://jnnp.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?action=archive&journal=192 ↗
http://www.bmj.com/archive ↗
DOI:: 10.1136/jnnp-2020-325684 ↗
Languages:: English
ISSNs:: 0022-3050
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 17138.xml